arrow
R

Raja Rajalingam

university of california
H指数:44
被引数:6,104

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: A scan of pleiotropic immune mediated disease genes identifies novel determinants of baseline FVIII inhibitor status in hemophilia A

更正:对多效性免疫介导疾病基因的扫描识别出血友病A中基线FVIII抑制剂状态的新的决定因素

2025-09-250
PREAI
A scan of pleiotropic immune mediated disease genes identifies novel determinants of baseline FVIII inhibitor status in hemophilia A

对多效性免疫介导疾病基因的扫描识别出血友病A中基础FVIII抑制剂状态的新的决定因素

2025-04-220
PRE
Disentangling effects of the DR and DQ isomers encoded by the HLA class II haplotype DRB1*15:01/DQB1*06:02 to help establish the true risk allele for FVIII inhibitor development in Hemophilia A

区分由HLA-II类单倍型DRB1*15:01/DQB1*06:02编码的DR和DQ异构体的效应,以帮助确定血友病A中FVIII抑制剂发展的真实风险等位基因。

2025-04-090
OA
Understanding heterogeneity of human bone marrow plasma cell maturation and survival pathways by single-cell analyses

通过单细胞分析了解人骨髓浆细胞成熟和存活途径的异质性

2023-07-0117
OAAI
COVID-19 infection and vaccination rarely impact HLA antibody profile in waitlisted renal transplant candidates- a multicenter cohort
2023-04-014
OAAI
CD16+natural killer cells in bronchoalveolar lavage are associated with antibody-mediated rejection and chronic lung allograft dysfunction

支气管肺泡灌洗中的CD16自然杀伤细胞与抗体介导的排斥反应和慢性同种异体肺功能障碍有关

2023-01-017
OA
Quantitative HLA-class-II/factor VIII (FVIII) peptidomic variation in dendritic cells correlates with the immunogenic potential of therapeutic FVIII proteins in hemophilia A

树突状细胞中hla-ii类/因子VIII (FVIII) 的定量多肽变异与血友病A中治疗性FVIII蛋白的免疫原性潜力相关

2020-01-014
OAAI